India · Delayed Price · Currency is INR Persistent Systems Earnings Call Transcripts
Fiscal Year 2026
-
Q4 FY26 revenue grew 16.2% YoY to $436M, with strong BFSI and AI-driven growth. FY26 revenue reached $1.65B, EBIT margin improved to 15.6%, and PAT rose 33.2% YoY. Confident in $2B FY27 run-rate, with continued AI investments and robust client expansion.
-
Q3 FY2026 saw 17.3% YoY revenue growth to $422.5M, with strong client expansion and robust order book. Margins were impacted by new labor codes, but AI-driven platforms and strategic wins across verticals supported growth. Interim dividend increased to INR 22 per share.
-
Q2 FY26 saw 17.6% YoY revenue growth and 230 bps EBIT margin expansion, with broad-based gains across geographies and verticals. AI initiatives and strong deal wins underpin confidence in reaching the $2B FY27 target, despite macro uncertainties.
-
Q1 FY26 saw revenue grow 18.8% YoY to $389.7M, with EBIT margin at 15.5% and PAT up 38.7% YoY. BFSI led segment growth, while healthcare faced a temporary decline due to planned transitions. Management remains confident in achieving $2B revenue by FY27.
Fiscal Year 2025
-
Q4 FY25 revenue grew 20.7% YoY to $375.2M, with EBIT margin at 15.6% and PAT margin at 12.2%. Full-year revenue reached $1.41B (+18.8% YoY), driven by strong growth in healthcare, BFSI, and tech, with continued focus on AI and platform-led offerings. Dividend payout for FY25 is ₹35/share.
-
AI is entering a transformative phase, with agentic AI poised to revolutionize industries through autonomous, end-to-end processes. Enterprises will shift toward smaller, fine-tuned models for cost-effective, domain-specific solutions, while new engineering and verification skills become essential.
-
Q3 FY25 saw 19.9% year-on-year revenue growth to $360.2M, with EBIT margin at 14.9% and PAT up 30.4%. Healthcare and BFSI led segment growth, and the company remains confident in its $2B FY27 and $5B FY31 revenue aspirations, driven by AI and platformization.
-
Q2 FY25 saw 18.4% year-over-year revenue growth, 14% EBIT margin, and strong order bookings. HLS and BFSI led vertical growth, while AI-driven platforms and strategic acquisitions enhanced offerings. Management remains confident in continued growth and margin expansion, targeting $2B revenue by FY27.
-
Q1 FY 2025 saw 16% YoY revenue growth and 14% EBIT margin, with strong order wins and broad-based client expansion. Healthcare and BFSI led growth, while cost optimization and AI initiatives are set to drive future margin improvement.
Fiscal Year 2024
-
The AGM highlighted robust financial growth, strategic investments in AI, and strong governance. Key board changes, expanded CSR initiatives, and a focus on platform-driven services were discussed, with all resolutions presented for voting and stakeholder questions addressed.